Asgard Therapeutics selects Exothera to bring their viral vector-based immunotherapy candidate AT-108 to clinical trial stage
June 11, 2024

June 11, 2024
June 6, 2024
June 5, 2024
May 29, 2024
May 29, 2024
May 22, 2024
May 15, 2024
May 15, 2024
May 15, 2024
March 16, 2026
Arctoris today announces the launch of its Biophysics Centre of Excellence, a major expansion of infrastructure, expertise and strategic partnerships ...
March 10, 2026
Foundational synthesis technology enables scalable modified 100-400nt RNA constructs, speeding design cycles and improving genome-editing precision Ci...
February 25, 2026
Epigenica today announces the launch of EpiFinder™ cNUC, a truly unique product for liquid biopsies that significantly expands the capabilities of epi...

Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225